AstraZeneca Newsroom

Health Care Down Despite Bristol Myers Rally -- Health Care Roundup

Dow Jones05:33

AstraZeneca China Operating Normally Amid Investigations

China DailyOct 31 13:28

Express News | AstraZeneca China internal memo: The operation of the company is normal, and the general manager of China will continue to lead the company.

BreakingsOct 31 07:40

LUNGevity Foundation and Living Beyond Breast Cancer Partner to Bring the No One Missed Campaign to the Breast Cancer Community

PR NewswireOct 31 01:11

European Equities Traded in the US as American Depositary Receipts Down Sharply in Wednesday Trading

MT NewswiresOct 30 23:08

Express News | Astrazeneca China President Wang Lei is cooperating with the investigation.

BreakingsOct 30 21:50

AstraZeneca Reports Ongoing Investigation Against AstraZeneca China President

MT NewswiresOct 30 21:34

AstraZeneca Senior Executive Is Under Investigation by Chinese Authorities

WSJOct 30 21:17

Daiichi Sankyo And AstraZeneca Launch Three Phase 3 Trials For Datopotamab Deruxtecan-Based Combinations In Advanced Nonsquamous NSCLC; TROPION-Lung10, Lung14, And Lung15 Studies Target High PD-L1 Expression And EGFR Mutations With First Patients Dosed

BenzingaOct 30 20:03

AION Labs Launches New AI Startup to Accelerate Identification of Active Small Molecules for Drug Discovery

PR NewswireOct 29 20:30

Astrazeneca (AZN.US) has been approved for clinical trials in china for a new class 1 anti-cancer drug.

B-cell malignancies are a type of malignant disease originating from B lymphocytes.

Zhitong FinanceOct 29 10:11

AstraZeneca Shares Are Trading Higher. The European Union Approved the Company's Fasenra as an Add-on Treatment as an Add-on Treatment for Adult Patients With Relapsing or Refractory Eosinophilic Granulomatosis With Polyangiitis.

BenzingaOct 29 01:26

Express News | Monopar Therapeutics Shares Down 17.3% Premarket; AstraZeneca Reports 9.9% Stake in Co

BreakingsOct 28 18:51

Express News | AstraZeneca Reports 9.9% Passive Stake in Monopar Therapeutics as of Oct 23 - SEC Filing

BreakingsOct 28 18:09

AstraZeneca's EGPA Add-on Treatment Receives EU Approval

MT NewswiresOct 28 15:31

Express News | On the second day of the 2024 national talks, the morning negotiations may be deadlocked. Representatives of Astrazeneca and Akeso will leave at one o'clock in the afternoon.

BreakingsOct 28 14:03

Fasenra Approved in the EU for Eosinophilic Granulomatosis With Polyangiitis

AstraZeneca Oct 28 12:00

Express News | The second day of the medical insurance negotiation has started! Hengrui, astrazeneca, and others have entered the scene.

BreakingsOct 28 08:15

RayonGene's senior management is suspected of changing the charges to fraud, and Astrazeneca was once its main client.

Reangene was established in 2012 and is a genetic testing company focusing on the field of oncology.

lanjinger.comOct 26 15:24

Express News | Beigene Shen Zhou senior executive Yin Min is under investigation for suspected smuggling.

BreakingsOct 26 08:34